Global Urology Laser Market Size USD 1605.41 Million By 2030 | CAGR of 5.51%

Introduction

Numerous urological disorders, including benign prostatic hyperplasia, non-muscle-invasive bladder cancer, and urolithiasis, are treated with medical devices known as urological lasers. The urinary channel is widened, and a laser melts (vaporizes) extra prostate tissue. Prostates under 40 ml can be treated safely and effectively with Prostate Holmium Laser Ablation (HoLAP). Patients benefit from HoLAP because of a low bleeding rate and short hospital stay.

Market Dynamics

Increasing Prevalence of Urological Disorders Drives the Global Market

A few major urologic diseases include prostatitis, urolithiasis, overactive bladder, interstitial (also known as painful bladder syndrome), urinary tract infections, prostate and bladder cancer, hematuria, and erectile dysfunction (ED). The growing burden of these diseases is profoundly impacting the rising morbidity and mortality rates worldwide. Urolithiasis is a common urologic disorder with a substantial financial burden on the global healthcare system. According to the US Department of Health and Human Services, chronic kidney disease (CKD) affects around 15% of adult US citizens. Additionally, urinary tract infections (UTIs), which can affect people of all ages, are among the most common microbiological ailments. The growing prevalence of these disorders drives the global urology laser market over the forecast period. 

Growing Cases of Benign Prostatic Hyperplasia (BPH) Creates Tremendous Opportunities

Males frequently experience benign prostatic hyperplasia, a medical condition that causes the prostate gland to enlarge. Common signs of BPH include frequent urination, difficulties initiating urine, a weak urinary system, and trouble emptying the bladder. Most BPH patients are elderly, and as the senior population grows, the disease burden increases, increasing the demand for laser therapy in this market. Additionally, bladder cancer risk is higher in the elderly population, which is anticipated to raise the disease's global burden and drive market growth.

Regional Analysis

North America is the most significant revenue contributor to the global urology laser market and is expected to grow at a CAGR of 5.39% during the forecast period. The United States is anticipated to be the world's largest market for urology lasers due to the rising prevalence of urological disorders like bladder cancer and urinary incontinence, as well as the preference for minimally invasive procedures due to their quicker recovery times and lower risk of complications. The emergence and use of cutting-edge technologies contribute to the market under study growth in the United States. Additionally, Canada also makes large expenditures on healthcare. The CO2RE laser, a fully integrated CO2 workstation, has been licensed by Health Canada to treat adult women's stress urinary incontinence (SUI) and genitourinary syndrome of menopause (GSM). These factors are anticipated to fuel market growth in the nation over the forecast period.

Europe is expected to grow at a CAGR of 5.61%, generating USD 409.09 million during the forecast period. The United Kingdom has a well-established healthcare system, and foreign businesses operate there. The London Clinic provides specialized therapy, which includes laser therapies for benign prostate enlargement. About a third of males over 50 in the UK are affected by this common condition. The aging elderly population is likely to be affected by various urological problems. Munich-Planegg, one of Germany's leading hospitals, treats about 10,000 patients yearly, and approximately 3,000 are admitted for inpatient care. The market-leading surgical designer of thulium and holmium lasers with a basis in Germany, LISA Laser Products OHG, has been acquired by OmniGuide to treat urological and other soft-tissue-related ailments that benefit from minimally invasive surgery.

The expanding Chinese urology laser market is primarily driven by the rising prevalence of urological illnesses and the nation's well-established healthcare system. Hospitals in China progressively incorporate cutting-edge technology, which bodes well for the country's healthcare system. The demand for laser therapy in India is rising due to the nation's aging population, improved acceptance of cutting-edge technology, and growing awareness. The India Brand Equity Foundation (IBEF) asserts significant room for improvement in healthcare services given the increasing proportion of GDP devoted to healthcare spending. According to a 2018 study titled "Kidney Stone Disease: An Update on Current Concepts, " the prevalence and recurrence rates of kidney stone disease are increasing." About 12% of Indians have urinary stones, and 50% may lose kidney function. The nation may see increased demand for laser therapy as a medical treatment.

Key Highlights

• The global urology laser market was valued at USD 990.70 million in 2021. It is projected to reach USD 1,605.41 million by 2030, growing at a CAGR of 5.51% during the forecast period (2022-2030). 
• Based on laser type, the global urology laser market is bifurcated into holmium laser systems, diode laser systems, thulium laser systems, and other laser types. The holmium laser system segment is the highest contributor to the market and is expected to grow at a CAGR of 5.80% during the forecast period.
• Based on application, the global urology laser market is bifurcated into benign prostatic hyperplasia, urolithiasis, non-muscle-invasive bladder cancer, and other applications. The benign prostatic hyperplasia segment owns the highest market share and is expected to grow at a CAGR of 5.39% during the forecast period.

• North America is the most significant revenue contributor to the global urology laser market and is expected to grow at a CAGR of 5.39% during the forecast period.

Competitive Players

Competitive Players

The global urology laser market’s major key players are Allengers, Biolitec AG, Boston Scientific Corporation, Cook Group, El.En. Group, Lumenis, Medtronic, Olympus Corporation, OmniGuide Holdings Inc., Richard Wolf GmbH, and Surgical Lasers Inc.

Recent Developments

Market News

• In May 2021, UCI Health urologists tested a new laser technology capable of reducing even large kidney stones to dust that can be suctioned or flushed from the body.

Segmentation

Global Urology Laser Market: Segmentation

By Laser Type

• Holmium Laser System
• Diode Laser Systems
• Thulium Laser System
• Other Laser Types

By Applications

• Benign Prostatic Hyperplasia
• Urolithiasis
• Non-Muscle-Invasive Bladder Cancer
• Other Applications

By Regions

• North America
• Europe
• Asia-Pacific
• LAMEA